Generic And Branded Mifepristone Remain On US Market Following Supreme Court Stay
No New Restrictions Will Be Placed On The Drug As Court Cases Play Out
GenBioPro will be able to continue selling its generic mifepristone, after the Supreme Court overruled a stay from the Fifth Circuit which could have seen generic approval rescinded and significant restrictions placed on the drug’s use.
